ATE396203T1 - Auf peptiden basierende immunisierungstherapie zur behandlung von atheriosclerose - Google Patents
Auf peptiden basierende immunisierungstherapie zur behandlung von atherioscleroseInfo
- Publication number
- ATE396203T1 ATE396203T1 AT04775345T AT04775345T ATE396203T1 AT E396203 T1 ATE396203 T1 AT E396203T1 AT 04775345 T AT04775345 T AT 04775345T AT 04775345 T AT04775345 T AT 04775345T AT E396203 T1 ATE396203 T1 AT E396203T1
- Authority
- AT
- Austria
- Prior art keywords
- peptide
- atheriosclerosis
- treatment
- cardiovascular diseases
- immunization therapy
- Prior art date
Links
- 238000002649 immunization Methods 0.000 title abstract 2
- 230000003053 immunization Effects 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- 230000000302 ischemic effect Effects 0.000 abstract 2
- 101710095342 Apolipoprotein B Proteins 0.000 abstract 1
- 102100040202 Apolipoprotein B-100 Human genes 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000010125 myocardial infarction Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0012—Lipids; Lipoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0302422A SE0302422D0 (sv) | 2003-09-11 | 2003-09-11 | Peptide-based immunization therapy for treatment of atherosclerosis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE396203T1 true ATE396203T1 (de) | 2008-06-15 |
Family
ID=28787306
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04775345T ATE396203T1 (de) | 2003-09-11 | 2004-08-30 | Auf peptiden basierende immunisierungstherapie zur behandlung von atheriosclerose |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US8436139B2 (de) |
| EP (1) | EP1682578B1 (de) |
| AT (1) | ATE396203T1 (de) |
| DE (1) | DE602004014012D1 (de) |
| DK (1) | DK1682578T3 (de) |
| ES (1) | ES2309562T3 (de) |
| SE (1) | SE0302422D0 (de) |
| WO (1) | WO2005023864A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030105003A1 (en) | 2001-04-05 | 2003-06-05 | Jan Nilsson | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| SE0302422D0 (sv) * | 2003-09-11 | 2003-09-11 | Forskarpatent I Syd Ab | Peptide-based immunization therapy for treatment of atherosclerosis |
| EP3070477B1 (de) * | 2007-12-05 | 2019-02-20 | The Cleveland Clinic Foundation | Trimethylaminverbindungen als prädiktoren von kardiovaskulärer erkrankung |
| CU23736A1 (es) | 2009-05-04 | 2011-11-15 | Centro Inmunologia Molecular | Anticuerpos que reconocen sulfatidos y proteoglicanos sulfatados y su uso |
| US8506964B2 (en) | 2010-02-05 | 2013-08-13 | Cardiovax, Llc | Fusion proteins and related compositions, methods and systems for treatment and/or prevention of atherosclerosis |
| EP2637689A2 (de) | 2010-11-12 | 2013-09-18 | Cedars-Sinai Medical Center | Immunmodulatorische verfahren und systeme zur behandlung und/oder prävention von bluthochdruck |
| US9205139B2 (en) | 2010-11-12 | 2015-12-08 | Cardiovax, Llc | Immunomodulatory methods and systems for treatment and/or prevention of aneurysms |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4970144A (en) * | 1984-12-31 | 1990-11-13 | International Genetic Engineering | Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use |
| US5972890A (en) * | 1988-05-02 | 1999-10-26 | New England Deaconess Hospital Corporation | Synthetic peptides for arterial imaging |
| US5408038A (en) * | 1991-10-09 | 1995-04-18 | The Scripps Research Institute | Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides |
| EP0671926B1 (de) * | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunmodulierende peptide |
| KR0185334B1 (ko) * | 1995-11-02 | 1999-04-01 | 김은영 | 인간 혈장 아포지단백질 비-100에 결합하는 생쥐 항체를 암호하는 씨디엔에이 |
| US6635623B1 (en) * | 1997-06-13 | 2003-10-21 | Baylor College Of Medicine | Lipoproteins as nucleic acid vectors |
| US6156315A (en) * | 1997-10-10 | 2000-12-05 | The Trustees Of Columbia University In The City Of New York | Method for inhibiting the binding of low density lipoprotein to blood vessel matrix |
| US20030157113A1 (en) * | 1999-12-28 | 2003-08-21 | Terman David S. | Compositions and methods for treatment of neoplastic disease |
| SE0000855D0 (sv) * | 2000-03-15 | 2000-03-15 | Karolinska Innovations Ab | Antigenic composition useful as a vaccine against atherosclerosis |
| US20030105003A1 (en) * | 2001-04-05 | 2003-06-05 | Jan Nilsson | Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| SE0103754L (sv) * | 2001-04-05 | 2002-10-06 | Forskarpatent I Syd Ab | Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid |
| AU2002348241A1 (en) * | 2001-11-24 | 2003-06-10 | Image Analysis, Inc. | Automatic detection and quantification of coronary and aortic calcium |
| WO2003087768A2 (en) * | 2002-04-12 | 2003-10-23 | Mitokor | Targets for therapeutic intervention identified in the mitochondrial proteome |
| SE0302422D0 (sv) * | 2003-09-11 | 2003-09-11 | Forskarpatent I Syd Ab | Peptide-based immunization therapy for treatment of atherosclerosis |
-
2003
- 2003-09-11 SE SE0302422A patent/SE0302422D0/xx unknown
-
2004
- 2004-08-30 DK DK04775345T patent/DK1682578T3/da active
- 2004-08-30 DE DE602004014012T patent/DE602004014012D1/de not_active Expired - Lifetime
- 2004-08-30 ES ES04775345T patent/ES2309562T3/es not_active Expired - Lifetime
- 2004-08-30 EP EP04775345A patent/EP1682578B1/de not_active Expired - Lifetime
- 2004-08-30 AT AT04775345T patent/ATE396203T1/de not_active IP Right Cessation
- 2004-08-30 WO PCT/SE2004/001239 patent/WO2005023864A1/en not_active Ceased
-
2006
- 2006-03-10 US US11/373,682 patent/US8436139B2/en not_active Expired - Fee Related
-
2007
- 2007-10-19 US US11/875,247 patent/US20080070265A1/en not_active Abandoned
-
2008
- 2008-10-31 US US12/262,284 patent/US20090092618A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2309562T3 (es) | 2008-12-16 |
| US20080070265A1 (en) | 2008-03-20 |
| EP1682578A1 (de) | 2006-07-26 |
| DE602004014012D1 (de) | 2008-07-03 |
| US8436139B2 (en) | 2013-05-07 |
| DK1682578T3 (da) | 2008-10-27 |
| HK1088909A1 (en) | 2006-11-17 |
| WO2005023864A1 (en) | 2005-03-17 |
| US20090092618A1 (en) | 2009-04-09 |
| US20060233817A1 (en) | 2006-10-19 |
| EP1682578B1 (de) | 2008-05-21 |
| SE0302422D0 (sv) | 2003-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE510851T1 (de) | Auf peptiden basierende immunisierungstherapie zur behandlung von atherosklerose | |
| AR047729A1 (es) | Anticuerpos terapeuticos que se unen a la apolipoproteina e (apoe) | |
| AT500379B8 (de) | Tau-proteine | |
| MX2007013626A (es) | Anticuerpos dirigidos contra el peptido beta amiloide y procedimientos que usan los mismos. | |
| EA201000809A1 (ru) | АНТИТЕЛА, СПЕЦИФИЧЕСКИЕ В ОТНОШЕНИИ ПРОТОФИБРИЛЛЯРНОЙ ФОРМЫ БЕЛКА β-АМИЛОИДА | |
| NO20083793L (no) | Antistoffer mot amyloid-beta peptid | |
| WO2005018424A3 (en) | Antibodies specific for fibrillar amyloid and a procedure to detect fibrillar amyloid deposits | |
| ATE376559T1 (de) | Methoden der verhinderung und behandlung der alzheimer'schen krankheit | |
| AR033978A1 (es) | Molecula de anticuerpo con especificidad para factor de necrosis tumoral alfa humano y usos de las mismas | |
| DK1368060T3 (da) | HMGB1-proteininhibitorer og/eller antagonister til behandlingen af vaskulære sygdomme | |
| EA200400162A1 (ru) | N-(3-амино-2-гидроксипропил)замещенные алкиламидные соединения | |
| AR066987A1 (es) | Anticuerpo monoclonal contra proteina beta-amiloide | |
| CY1115014T1 (el) | ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ ΕΙΔΙΚΑ ΓΙΑ Αβ1-42 ΜΕ ΘΕΡΑΠΕΥΤΙΚΕΣ ΙΔΙΟΤΗΤΕΣ | |
| ATE382364T1 (de) | Von igf-bindungsprotein stammendes peptid | |
| MX2021010404A (es) | Anticuerpos que se unen a una forma escindida de calreticulina mutante, y agente de diagnostico, preventivo o terapeutico para las neoplasias mieloproliferativas. | |
| Peng et al. | Targeting a cysteine protease from a pathobiont alleviates experimental arthritis | |
| ATE396203T1 (de) | Auf peptiden basierende immunisierungstherapie zur behandlung von atheriosclerose | |
| RU2010129856A (ru) | Новая вакцина для лечения связанных с микобактерией нарушений | |
| DE50212280D1 (de) | Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren | |
| EA200501711A1 (ru) | Семейство секретируемых белков | |
| RU2010126590A (ru) | Новые аллергены пшеницы | |
| PL400309A1 (pl) | Kwasy nukleinowe, proteiny oraz przeciwciala BTL-II | |
| DE602006017806D1 (de) | Behandlung von neurodegeneration | |
| ATE526400T1 (de) | Metalloproteaseproteine | |
| ATE340804T1 (de) | Hyphenspezifische faktoren aus candida albicans |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |